Review Papers Against Their Own Results

 Quick Explanation Copied

 Long Explanation

Core Synthesis and Evidence Base

The review by Srikantan, Tominaga and Gorospe synthesized an emerging concept: HuR's post-transcriptional outcomes cannot be explained by TTR-RBP interactions alone, but depend on microRNAs sharing the same mRNAs Srikantan et al., HuR-microRNA interplay review. Its central evidence is a curated table of eight shared targets:

The cooperative arm is anchored by the landmark finding that HuR recruits let-7/RISC to repress c-Myc, with binding sites over 100 nt apart — implying non-steric, structural cooperation Kim et al., HuR recruits let-7/RISC to MYC.

Transcriptome-Wide Scale

The review's genomic support comes from parallel PAR-CLIP studies: miRNA sites sit adjacent to (not usually overlapping) HuR sites, and overlapping-site transcripts were preferentially miRNA-regulated Mukherjee et al., HuR PAR-CLIP/RIP-Chip integrative mapping:

Note the asymmetry: only ~4% of PAR-CLIP targets show 3'UTR HuR-Ago overlap, so genome-wide competition appears far less prevalent than the pairwise examples imply — a caveat the review itself concedes.

Blind Spots, Then and Now

• The conformational-switch model was never directly tested here. The review proposes SHAPE probing but performs none; 14 years on, direct structure-level proof remains scarce.
• The dichotomy was later complicated: miR-155-5p positively regulates HuR via its 3'UTR in HT-29 cells (a single-cell-line, in vitro study) miR-155-5p positively regulates HuR in colon cancer, and miR-466i-HuR competition was confirmed in mouse Th17 cells for GM-CSF HuR-miR-466i competition in Th17 cells.
• The mechanism behind HuR lowering miR-16 was unknown in 2012 but later partially resolved: HuR ubiquitination at multivesicular bodies drives EV export of bound miR-122 in starved hepatic cells, validating the review's 'sponge/export' speculation HuR-driven miR-122 extracellular export.
• HuR and Ago2 also jointly promote target-dependent miRNA biogenesis Target-dependent miRNA biogenesis via HuR/Ago2 — a feedback layer absent from the review.
• Therapeutically, HuR remained a valid oncology target: engineered bioPROTAC degradation of endogenous HuR cut xenograft growth ~78% TRIM21 bioPROTAC degrades HuR in tumors, consistent with the review's tumor-biology framing (miR-519 suppresses tumors by repressing HuR miR-519 tumor suppression via HuR repression).

Confidence: The review's descriptive claims are well-supported by the cited primary studies (strong); its mechanistic conformational model remains conjecture (weak). What would change this verdict: direct structural evidence that HuR binding remodels a shared 3'UTR, or transcriptome-wide failure of HuR-Ago proximity to predict regulatory outcome.

 BGPT Paper Review

Study Novelty

In 2012, framing HuR-microRNA crosstalk as a general regulatory layer was fresh and integrative, but the review synthesizes others' primary discoveries (CAT1/miR-122, MYC/let-7, PAR-CLIP maps) rather than generating new data, capping novelty below groundbreaking.

Scientific Quality

Well-organized, honestly flags its own preliminary understanding and the scarcity of structural evidence, and proposes concrete next methods (SHAPE, pulsed SILAC). Weaknesses: no quantitative synthesis or meta-analysis, a single-figure schematic model presented without direct proof, and reliance on few mRNAs and one HEK293 cell line for genome-wide inference. No conflicts declared; NIA/NIH intramural funding.

Study Generality

The competition/cooperation framework generalizes in principle to all TTR-RBPs and was later confirmed in immune and metabolic contexts, but the evidentiary base spans only eight mRNAs and human cancer cell lines, limiting demonstrated generality.

Study Usefulness

Highly useful: it organized a scattered literature into testable categories, predicted transcriptome-scale patterns, and correctly anticipated the miRNA-sponge/export and structural-switch questions that subsequent work (miR-122 EV export, target-dependent biogenesis) pursued.

Study Reproducibility

As a review it generates no data, so reproducibility reflects traceability: claims map cleanly to cited primary studies with GEO-deposited datasets (e.g., GSE29780), but the review reports no effect sizes, statistics, or systematic inclusion criteria for its examples.

Explanatory Depth

Articulates plausible mechanisms (conformational switching, P-body vs polysome sequestration, phosphorylation-dependent HuR binding) with genuine insight, but most mechanisms are inferred from binding-site geometry rather than measured, leaving causal depth at the hypothesis level.